Fintel reports that on March 14, 2025, Oppenheimer upgraded their outlook for Nektar Therapeutics (NasdaqCM:NKTR) from ...

In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Ferguson (NASDAQ:FERG – Free Report) had its price target reduced by Oppenheimer from $234.00 to $189.00 in a report published on Wednesday morning,Benzinga reports. Oppenheimer currently has an ...

Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s ...

AI, as an immortal intelligence, does not experience death, fear, or existential urgency. This raises profound questions: How ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

Oppenheimer will be released on Netflix on March 21, 2025. The movie will be made available to stream on OTT platform with a ...

Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.

Adobe (NASDAQ:ADBE – Get Free Report) had its price target reduced by equities research analysts at Oppenheimer from $560.00 ...

Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...